MYC activation is a hallmark of cancer initiation and maintenance.
By Meital Gabay, Yulin Li, Dean W. Felsher. Cold Spring Harbor Perspectives in Medicine, 2014
761 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/a0ac75781e461cc2159038967125e50bbfe51433
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- C. Crews
- Kanak Raina
- Jing Lu
- J. Hines
- Y. Qian
- M. Altieri
- Jing Wang
- J. Winkler
Citations in the corpus
- Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. (2015, background): “ARV-825 Leads to a Superior Effect on BLCell Apoptosis Induction Compared with Small-Molecule Inhibitors c-MYC is a pleiotropic oncoprotein involved in many hallmarks of cancer, including cell cycle, senescence, proliferation, and apoptosis, depending on the tumor (Gabay et al., 2014).”